ADVM vs JNJ: Which Stock is Better?

Side-by-side comparison of Adverum Biotechnologies Inc and Johnson & Johnson in 2026

Comparison Updated:

ADVM

Adverum Biotechnologies Inc

JNJ

Johnson & Johnson

$232.77

Key Metrics Comparison

MetricADVMJNJWinner
Market Cap$47.63M$375.37BJNJ
P/E RatioN/A17.35JNJ
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze ADVM

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADVM or JNJ a better investment?

Comparing ADVM and JNJ: Adverum Biotechnologies Inc has a market cap of $47.63M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADVM and JNJ?

ADVM (Adverum Biotechnologies Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADVM or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ADVM or JNJ?

Both ADVM and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: ADVM or JNJ?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: ADVM or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $47.63M for ADVM.

Should I buy ADVM or JNJ in 2026?

Both ADVM and JNJ have investment merit. ADVM trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADVM and JNJ stock?

Key differences: Market Cap ($47.63M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy ADVM or JNJ in 2026?

The choice between ADVM and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between ADVM and JNJ?

ADVM (Adverum Biotechnologies Inc) has a market cap of $47.63M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.

Popular Stock Comparisons